| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 790,909,047 | 833,728,170 | -5.135 | 791,827,797 | -0.116 |
| Gross Profit (Loss) | 385,259,335 | 372,598,003 | 3.398 | 368,859,731 | 4.446 |
| Operational Profit (Loss) | 192,085,715 | 189,301,115 | 1.47 | 119,688,569 | 60.487 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 173,138,809 | 171,871,096 | 0.737 | 152,574,252 | 13.478 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 172,515,689 | 176,723,126 | -2.38 | 156,953,969 | 9.914 |
| All figures are in (Actual) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 3,134,506,371 | 2,700,529,204 | 16.07 |
| Profit (Loss) per Share | 2.16 | 2.15 | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | – | – | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Revenue decreases in general due to: Decrease in revenue in the following segments: a) Steel Industry b) Specialty chemical. While noting that there is slight increase in revenue in pharmaceuticals segment. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Net profit Increases in general due to: 1. Increase in Gross Profit in the following segments: a) Pharmaceuticals b) Steel Industry 2. Decrease in finance costs mainly in the following segments: a) Specialty Chemical b) Pharmaceuticals. While noting that there is decrease in other income, net in other segment. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | Sales decrease in general due to: Decrease in sales in steel segment. While noting that there is increase in sales in the pharmaceuticals segment. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | Net profit Increases in general due to: 1. Increase Gross Profit in Profit in the following segments: a. Pharmaceuticals b. Specialty chemical While noting that there is decrease in Gross Profit in Steel industries. 2. Decrease in General and administrative expenses in following sectors: a) Steel industries b) Specialty chemical 3. Decrease in Provision for impairment of financial assets expenses in following sectors: a) Steel industries b) Specialty chemical While noting that there is decrease in share in profit from unconsolidated subsidiary. |
| Statement of the type of external auditor’s report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | N\A |
| Reclassification of Comparison Items | Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. |
| Additional Information | Net Shareholders’ Equity at the end of the period was SR 3,133,945,566/- compared to SR 2,707,857,633 /- at the end of the similar period last year with an increase of 16%. |